Over recent decades, diabetes mellitus (DM) has become one of the major public healthcare problems worldwide. It is estimated that 415 million adults have diabetes worldwide, and a further 318 million adults are estimated to have impaired glucose tolerance, and thus, be at high risk of developing diabetes in the future.
MSC's in Type II Diabetes May 2017Mesenchymal stem cell therapy in type 2 diabetes mellitus
By nsc116|2018-07-16T13:20:51+00:00July 16th, 2018|Diabetes, Mesenchymal Stem Cells|Comments Off on Mesenchymal stem cell therapy in type 2 diabetes mellitus